| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.34 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |